PHARMASSET INC Net Income (Loss), Including Portion Attributable to Noncontrolling Interest
PHARMASSET INC reported Net Income (Loss), Including Portion Attributable to Noncontrolling Interest of -$25.22 million for the 3-month period ending 2011-09-30, per its 10-K filed 2011-11-14.
Discontinued › Income Statement
us-gaap:ProfitLoss · last filed 2011-11-14
- PHARMASSET INC net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2011-09-30 was -$25.22M.
- PHARMASSET INC net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2011-06-30 was -$22.61M.
- PHARMASSET INC net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2011-03-31 was -$19.86M.
- PHARMASSET INC net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2010-12-31 was -$23.50M.
- PHARMASSET INC net income (loss), including portion attributable to noncontrolling interest for fiscal 2011 was -$91.19M.
- PHARMASSET INC net income (loss), including portion attributable to noncontrolling interest for fiscal 2010 was -$66.08M.
- PHARMASSET INC net income (loss), including portion attributable to noncontrolling interest for fiscal 2009 was -$55.59M.
| Period end | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 3 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 6 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 9 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 12 month |
|---|---|---|---|---|
| 2011-09-30 | -$25.22M 10-K · filed 2011-11-14 | -$47.83M derived: sum of 2 quarters · filed 2011-11-14 | -$67.68M derived: sum of 3 quarters · filed 2011-11-14 | -$91.19M 10-K · filed 2011-11-14 |
| 2011-06-30 | -$22.61M 10-K · filed 2011-11-14 | -$42.46M derived: sum of 2 quarters · filed 2011-11-14 | -$65.97M 10-Q · filed 2011-08-09 | -$86.10M derived: sum of 4 quarters · filed 2011-11-14 |
| 2011-03-31 | -$19.86M 10-K · filed 2011-11-14 | -$43.36M derived: sum of 2 quarters · filed 2011-11-14 | -$63.49M derived: sum of 3 quarters · filed 2011-11-14 | -$79.51M derived: sum of 4 quarters · filed 2011-11-14 |
| 2010-12-31 | -$23.50M 10-K · filed 2011-11-14 | -$43.63M derived: sum of 2 quarters · filed 2011-11-14 | -$59.66M derived: sum of 3 quarters · filed 2011-11-14 | -$75.72M derived: sum of 4 quarters · filed 2011-11-14 |
| 2010-09-30 | -$20.13M 10-K · filed 2011-11-14 | -$36.15M derived: sum of 2 quarters · filed 2011-11-14 | -$52.21M derived: sum of 3 quarters · filed 2011-11-14 | -$66.08M 10-K · filed 2011-11-14 |
| 2010-06-30 | -$16.02M 10-K · filed 2011-11-14 | -$32.08M derived: sum of 2 quarters · filed 2011-11-14 | -$45.95M 10-Q · filed 2011-08-09 | |
| 2010-03-31 | -$16.06M 10-K · filed 2011-11-14 | -$29.93M derived: sum of 2 quarters · filed 2011-11-14 | ||
| 2009-12-31 | -$13.87M 10-K · filed 2011-11-14 | |||
| 2009-09-30 | -$55.59M 10-K · filed 2011-11-14 |